36 citations
,
November 2005 in “Journal of The American Academy of Dermatology” This article discusses the potential of latanoprost for treating alopecia areata, but notes that well-controlled studies are still needed to confirm its effectiveness.
20 citations
,
August 2005 in “Journal of Cutaneous Medicine and Surgery” This case study reported that an experimental hair transplant provided eight months of relief from eyebrow alopecia areata for a patient previously unresponsive to standard medical therapy, with ongoing manageable results using intralesional cortisone.
7 citations
,
August 2005 in “Journal of Cutaneous Medicine and Surgery” This case report describes a patient with chronic eyebrow alopecia areata who experienced 8 months of symptom relief after an experimental hair transplant, improving response to cortisone injections afterward.
4 citations
,
November 2020 in “Journal of Investigative Dermatology Symposium Proceedings” The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.
June 2025 in “Frontiers in Medicine” This study observed that omalizumab may induce alopecia, particularly in females aged 18-60, though establishing a direct cause-effect link remains challenging. Alopecia areata was noted as a possible uncommon, yet transient, hair loss type associated with omalizumab.